Access to Medicines, Devices & Services
FIP Development Goal 18 Education & Workforce Element
Globally, we will have:
Strategies in place to widen access to medicines & services through a responsive, capable, available and well-distributed pharmaceutical workforce.
Mechanisms
- Ensure workforce development strategies are in line with services in needs (FIP Development Goal 7 [w]).
- Develop medicines expertise competencies in the workforce to deliver quality care (FIP Development Goal 14 [w]).
- Link gender and diversity balances in the workforce with optimisation of service delivery such as to improve access to minority groups and special patient populations (FIP Development Goal 10 [w]) .
- Utilise workforce intelligence and date to inform strategies for workforce production, distribution, and capacity improvement (FIP Development Goal 12 [w]).
FIP Development Goal 18 Practice Element
Globally, we will have:
Systems in place to optimise access to effective medicines and pharmaceutical care services through appropriate supply chains, quality standards, self-care & prevention services, and affordability and fair pricing policies.
Mechanisms
- Develop systems and structures to ensure appropriate supply of and access to medicines and other health products (including medical devices).
- Develop and implement contingency plans for shortages of medicines and medical devices.
- Develop and implement quality standards and guidelines to ensure access to safe and effective medicines and medical devices, prevent the entry of substandard or falsified medicines in the legitimate supply chain, and ensure the stability of medicines in different environmental conditions, in addition to other safety and quality indicators.
- Advocate for and contribute to the development and implementation of policies and initiatives addressing affordability and fair pricing of medicines, medical products and devices, and services that aim to ensure equitable access for all, and especially for fragile and vulnerable communities, as well as access to specialised and innovative therapies
- Ensure access to optimal treatment outcomes and promote the responsible and optimal use of medicines through the provision of appropriate pharmaceutical care, considering advanced capabilities.
- Develop and implement pharmaceutical workforce and education policies to increase capacity and competence to increase access to pharmaceutical expertise in primary health care settings, in collaboration with the wider health care team and system.
FIP Development Goal 18 Science Element
Globally, we will have:
Access to innovative science and information, new/innovative therapies, new delivery/ manufacturing processes.
Mechanisms
- Collaborate with stakeholders to achieve harmonisation of regulatory processes around the world.
- Promote dissemination of accurate scientific information on innovative medical products.
- Define mechanisms to increase access to innovative medical products at affordable cost.
- Educate, train, and mentor pharmaceutical scientists to develop effective and affordable medical products.
11 January 2022
FIP Statement of Principle: Accelerating vaccine equity for pharmacy teams on the front line (2021)
Read Publication
11 January 2022
Online pharmacy operations and distribution of medicines: Global Survey Report - FIP Community Pharmacy Section (2021)
Read Publication
10 January 2022
FIP digital health in pharmacy education: Developing a digitally enabled pharmaceutical workforce (2021)
Read more
9 December 2024
Artificial Intelligence in Drug Development and Clinical Trials
26 November 2024
Alcohol consumption and dependence: The role of pharmacists in prevention, support and management
20 November 2024
Reframing the role and impact of pharmacy in Chronic Obstructive Pulmonary Disease (COPD) Care
18 October 2024
Empowering pharmacists in menopause care: Expanding roles and patient support
17 October 2024
Use of heat therapy for the management of musculoskeletal pain in the community pharmacy: New FIP guidance
3 October 2024
The Oxempic® Pandemic: time to review our ethical obligations. An examination of drug shortages, off-label prescribing and patient needs
24 July 2024
Promoting and communicating the value of self-care: Self-care does not mean no care
11 July 2024
Empoderar a los farmacéuticos para apoyar la deshabituación tabáquica en la región de las Américas
2 July 2024
Empowering pharmacists to support tobacco cessation in the Eastern Mediterranean Region
25 June 2024
Empowering pharmacists to support tobacco cessation in Western Pacific Region
31 May 2024
Leveraging pharmacists for tobacco cessation: New policy tools, evidence, and success stories
23 May 2024
Closing the medicines supply gap in the African region: The East African perspective
20 March 2024
The role of pharmacists in the prevention and management of periodontal disease and other common oral health conditions
4 March 2024
Obesity: understanding the disease, nutritional approaches and new pharmacological interventions
1 February 2024
Optimising cancer care: community pharmacy strategies to support patients on oral treatment
30 January 2024
Climate change and vector-borne neglected tropical diseases: Positioning pharmacy practice to drive awareness, prevention and management
22 November 2023
Sharing perspectives on the pharmacists’ needs in humanitarian settings
17 November 2023
Integrating point-of-care testing in community pharmacy practice: Findings from a global intelligence report
16 November 2023
Men's health from a pharmacy angle: Supporting men with erectile dysfunction and improving awareness of prostate cancer
15 November 2023
The role of the pharmacist in Chronic obstructive pulmonary disease (COPD)
14 November 2023
Reaching at-risk and vulnerable groups: Pharmacy’s role in inclusive vaccination
25 October 2023
Celebrating the 5th Anniversary of Astana Declaration: Pharmacists contributing to primary health care
13 October 2023
Pharmacy-based Common Ailment Schemes: Findings from a FIP global intelligence report
14 September 2023
Non-communicable diseases: Effective medication management and adherence
16 August 2023
Enabling life-course immunisation through pharmacy-based vaccination: Launch of a new FIP Pandemic Preparedness report
24 July 2023
Advancing Pharmaceutical Supply Chain Management: Strategies for Optimising Global Health Outcomes
3 July 2023
FIP Pharmacy Practice Research summer meeting for PhD students, postdoctoral fellows and supervisors
16 March 2023
The role of pharmacists in the prevention and management of sleep disorders
22 February 2023
Pregnant individuals
This video highlights the main benefits of vaccination, and which vaccines are recommended for pregnant individuals.
30 November 2022
Chronic respiratory diseases
This video highlights the main benefits of vaccination, and which vaccines are recommended for people living with chronic respiratory conditions.
30 November 2022
Cardiovascular diseases
This video highlights the main benefits of vaccination, and which vaccines are recommended for people living with cardiovascular diseases.
30 November 2022
Diabetes
This video highlights the main benefits of vaccination, and which vaccines are recommended for people living with diabetes.
17 November 2022
Facilitar el acceso a los medicamentos: Estudios de casos de reglamentación de bioexenciones de América Latina
27 October 2022
Special event on pandemic preparedness Pharmacy’s global responses to the COVID-19 pandemic
26 October 2022
Transforming pharmacy practice for improved care and management of cardiovascular diseases
4 October 2022
Transforming pharmacy practice for improved care and management of cancer
28 September 2022
Transforming pharmacy practice for improved care and management of chronic respiratory diseases
7 July 2022
Transforming pharmacy practice for improved care and management of mental health illnesses
22 June 2022
The role of pharmacists in diabetes prevention, screening, and management (French translation)
26 April 2022
The role of community pharmacies in COVID-19 booster vaccination: Opportunities and supply chain challenges in a post-pandemic scenario
4 November 2021
Sustainable and equitable access to vaccines: Establishing priorities and setting policies in the African region
28 October 2021
Sustainable and equitable access to vaccines: Establishing priorities and setting policies in the Western Pacific region
26 October 2021
Sustainable and equitable access to vaccines: Establishing priorities and setting policies in the South East Asian region
25 October 2021
FIP Global Summit on Primary Health Care: Pharmacists transforming vision into actions
21 October 2021
Joining forces across civil society organisations towards improved vaccination coverage
14 October 2021
Sustainable and equitable access to vaccines: Establishing priorities and setting policies in the European region
13 October 2021
Facilitating Access to Medicines – Scientific Rationale for the FIP Latin America Biowaiver Project
7 October 2021
Sustainable and equitable access to vaccines: Establishing priorities and setting policies in the Eastern Mediterranean region
1 October 2021
Acceso sostenible y equitativo a las vacunas: Establecimiento de prioridades y fijación de políticas en la región de las Américas
30 September 2021
Sustainable and equitable access to vaccines: Establishing priorities and setting policies in the Americas region
3 August 2021
Pharmacists’ experiences in crises in Lebanon: The Lebanese financial crisis, COVID-19 pandemic, and the Beirut Port blast.
6 July 2021
Pharmacists in long-term care facilities: Before, during and after the pandemic
24 June 2021
Pharmacy Practice Research Virtual Summer Meeting for PhD students, Postdoctoral fellows and supervisors
22 June 2021
Distribution of medicines and promotion of responsible self-care: Channels, changes and challenges
21 June 2021
The role of pharmacists in the prevention and management of vector-borne diseases: a perspective from the Eastern Mediterranean region
29 May 2021
La farmacia humanitaria durante el covid-19. Gestión de desafíos durante una nueva era
18 May 2021
Hearing from our heroes: Students and young pharmacists on the frontline Part 2
21 April 2021
El farmacéutico en la prevención y manejo de las enfermedades transmisibles por vectores: una perspectiva de la región de las Américas
7 April 2021
FIP “Setting goals for the decade ahead” | Episode 2 | FIP DG 18: Access to medicines, devices & services
23 January 2021
Humanitarian pharmacy during COVID-19 - Management of challenges during a new era
13 October 2020
Medicines use and quality
Chair: Paul Sinclair. Speakers: Tamara Peiró Zorrilla, Jan Saevels and Jephney John Redford Jacquet
22 July 2020
Medicine supply disruptions and shortages during the pandemic
Moderator: Ulf Janzon. Panellists: Propser Hiag, Joan Alexis, Joao Ferreira, J. Jayaseelan. Facilitators: Clement Haeck, Gerard Lee See
9 June 2020
Hearing from our heroes: Students and young pharmacists on the frontline Part 1
Panellists: Abrar Husaini, Anas Najjar, Nalukwago Mercy Kamya, Ramon Contrucci, Sara Ali Isaa and Sunil Shrestha
19 October 2019
Good distribution practices. Securing the supply chain
Speaker: Michael H. Anisfeld
2 September 2014
Updates about medication pricing regulation in the UAE and price standardisation in the GCC countries
Ola Ghaleb Al Ahdab, United Arab Emirates, Session A3, FIP congress Bangkok 2014
2 September 2014
Challenges in access to medicines in The Phillipines, including strategies for appropriate and responsible use of medicine
Leonila Ocampo, Philippines, Session A3, FIP congress Bangkok 2014
2 September 2014
Global and regional perspectives on access to and responsible use of antibiotics
Niyada Kiatying-Angsulee, Thailand, Session A3, FIP congress Bangkok 2014
1 September 2014
Cost of drug development
Ivo Abraham, USA, Session A1, FIP congress Bangkok 2014
1 September 2014
Role of the pharmacists to improve affordability (formulation, substitution, negotiation)
Cecile Mace, France, Session A1, FIP congress Bangkok 2014
1 September 2014
Pricing of pharmaceuticals: How are prices determined? - Pricing Schemes
Leonila Ocampo, Philippines, Session A1, FIP congress Bangkok 2014
1 September 2014
Differencing pricing and value-based pricing
Lloyd Sansom, Australia, Session A1, FIP congress Bangkok 2014
1 September 2014
Medicine shortage: An ever increasing threat: General overview - Summit feedback
Betty Chaar, Australia , Session A2, FIP congress Bangkok 2014
1 September 2014
Shelf life and compounding: rationale and safe measures to mitigate drug shortages
Bob DeChristoforo, USA, Session A2, FIP congress Bangkok 2014
1 September 2014
How can the supply chain guarantee continuity of supply?
Sherry Peister, Canada, Session A2, FIP congress Bangkok 2014
1 September 2014
Pharmacist's role in managing medicines shortages
Douglas Scheckelhoff, USA, Session A2, FIP congress Bangkok 2014The following FIP programmes of work and structures support the implementation of this Goal:
